Breakthrough in artificial sugars could revolutionize disease diagnosis and treatment

Scientists have found a way to create artificial sugars that could lead to better ways to diagnose and treat diseases more accurately than ever before.

Biden administration axes proposal to mandate more drug price transparency in Medicaid

Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and research costs of drugs that are driving up

September 26, 2024

Sanofi partners with Synthekine in immunology race

Synthekine is teaming up with Sanofi in a $40 million-plus collaboration to develop IL-10 receptor agonists for autoimmune and inflammatory diseases. The cytokine-focused biotech will

January 30, 2024

Big drugmakers have cut outside R&D spending amid broad pullback, key contractor warns

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.